| Price | 8.40p on 26-11-2025 at 07:30:29 |
|---|---|
| Change | 0.00p 0% |
| Buy | 8.50p |
| Sell | 7.30p |
| Last Trade: | Sell 100,000.00 at 8.20p |
| Day's Volume: | 0 |
| Last Close: | 8.40p |
| Open: | 0.00p |
| ISIN: | GB00BYV81293 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 2.20p - 9.00p |
| Market Capitalisation: | £89.19m |
| VWAP: | 0.00p |
| Shares in Issue: | 1.06b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 100,000 | 8.20p | Ordinary |
16:42:58 - 25-Nov-25 |
| Buy* | 250,000 | 8.40p | Ordinary |
16:39:27 - 25-Nov-25 |
| Buy* | 12,000 | 8.40p | Suspected BUY Trade |
16:35:06 - 25-Nov-25 |
| Buy* | 1,060 | 8.50p | Ordinary |
16:25:27 - 25-Nov-25 |
| Sell* | 70,000 | 8.33p | Ordinary |
16:14:51 - 25-Nov-25 |
| Sell* | 494 | 8.00p | SI Trade |
16:10:15 - 25-Nov-25 |
| Buy* | 250,000 | 8.40p | Ordinary |
16:09:37 - 25-Nov-25 |
| Buy* | 200 | 8.38p | Ordinary |
16:06:48 - 25-Nov-25 |
| Buy* | 1,500 | 8.26p | Ordinary |
15:52:29 - 25-Nov-25 |
| Buy* | 25,000 | 8.38p | Ordinary |
15:46:56 - 25-Nov-25 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 14th Nov 2025 7:03 am | RNS | Initiation of a Phase II Clinical Trial in Japan |
| 11th Nov 2025 7:00 am | RNS | ACCRUFeR Pediatric PK Results to be Presented |
| 7th Nov 2025 7:03 am | RNS | ACCRUFeR receives Authorisation by Korean Ministry |
| 23rd Oct 2025 7:00 am | RNS | Q3 2025 Trading Update |
| 14th Oct 2025 3:01 pm | RNS | Grant of Share Options to Chief Executive Officer |
| 1st Oct 2025 8:00 am | RNS | Total Voting Rights |
| 1st Oct 2025 7:02 am | RNS | Positive efficacy and tolerance in pediatric trial |
| 15th Sep 2025 7:00 am | RNS | £1.5 million placing supporting growth of ACCRUFeR |
| 4th Sep 2025 7:03 am | RNS | ACCRUFeR® assigned Priority Review in US by FDA |
| 3rd Sep 2025 2:17 pm | RNS | Interim results for the six months ended 30 Jun 25 |
